The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01X | Other antibacterials | |
4
|
J01XX | Other antibacterials | |
5
|
J01XX12 |
| Active Ingredient |
|---|
|
Lefamulin is a pleuromutilin antibacterial agent. It inhibits bacterial protein synthesis by interacting with the A- and P- sites of the peptidyl transferase centre (PTC) in the central part of domain V of the 23S rRNA of the 50S ribosomal subunit, preventing correct positioning of the tRNA. |
| Document | Type | Information Source | |
|---|---|---|---|
| XENLETA Concentrate and solvent for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XENLETA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| XENLETA Solution for injection / Film-coated tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.